Here are five details:
1. The company reported $73.6 million in second quarter revenue, a 12 percent increase year-over-year.
2. K2M’s U.S. complex spine segment brought in $21.8 million in revenue, up 7 percent year-over-year.
3. Within the U.S. minimally invasive surgery segment, K2M reported $8.7 million in revenue, a 1 percent decrease year-over-year.
4. K2M experienced the most growth in its U.S. degenerative segment generating $23.8 million in the second quarter, a 10 percent uptick year-over-year.
5. International revenue for the quarter reached $19.3 million, a 29.1 percent year-over-year increase.
To view the full financial report, click here.
More articles on devices and implants:
DePuy Synthes, Medtronic, NuVasive & more: 9 device company notes
These 3 companies dominate the global hip & knee surgical implants market
Wearable devices, patient data & the future of specialty surgical care: 6 Qs with VivaLNK’s CEO
